Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 3, 2012, Pages 586-591

  Wang, Pin Chao ^a   Hsu, Ching Sheng ^a   Tseng, Tai Chung ^b   Hsieh, Tsung Cheng ^a   Chen, Chien Hwa ^a   Su, Wei Chih ^a   Lin, Hans Hsienhong ^a   Wang, Chia Chi ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Asymptomatic erosive esophagitis; Gastroesophageal reflux disease; Helicobacter pylori; Paradox

Indexed keywords

ADULT; AGED; ARTICLE; ASYMPTOMATIC EROSIVE ESOPHAGITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOSCOPY; HELICOBACTER INFECTION; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SEX;

EID: 84863167560     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06881.x     Document Type: Article

References (32)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-17.
2. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J. Gastroenterol. 2009; 44: 518-34.
3. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J. Gastroenterol. Hepatol. 2000; 15: 230-8.
4. Isakov VA. GERD epidemiology: East and West. Eksp. Klin. Gastroenterol. 2004; 5: 117-21.
5. Camilleri M, Dubois D, Coulie B etal. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin. Gastroenterol. Hepatol. 2005; 3: 543-52.
6. Shaheen NJ, Hansen RA, Morgan DR etal. The burden of gastrointestinal and liver diseases, 2006. Am. J. Gastroenterol. 2006; 101: 2128-38.
7. Toghanian S, Wahlqvist P, Johnson DA, Bolge SC, Liljas B. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin. Drug. Investig. 2010; 30: 167-78.
8. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006; 101: 1900-20. quiz 43.
9. Lundell LR, Dent J, Bennett JR etal. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
10. Fennerty MB. The continuum of GERD complications. Cleve. Clin. J. Med. 2003; 70 (Suppl. 5): S33-50.
11. Fitzgerald RC. Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 2005; 3: 529-37.
12. Sampliner RE. Barrett's esophagus, a complication of GERD. Curr. Treat. Options. Gastroenterol. 2002; 5: 45-50.
13. Ronkainen J, Aro P, Storskrubb T etal. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-31.
14. Kodama M, Sato R, Murakami K, Fujioka T. Role of Helicobacter pylori in gastritis, gastric ulcer and gastric carcinogenesis. Nippon Shokakibyo Gakkai zasshi 2002; 99: 1303-11.
15. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Strategy for treatment of nonerosive reflux disease in Asia. World J. Gastroenterol. 2008; 14: 3123-8.
16. Shaw MJ, Talley NJ, Beebe TJ etal. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am. J. Gastroenterol. 2001; 96: 52-7.
17. Cao Y, Yan X, Ma XQ etal. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC gastroenterol. 2008; 8: 37.
18. Allmendinger G, Munch E, Guffarth G, Jetter E, Thomas F, Schmid E. The urease rapid test (CLO test). Attempt at statistical analysis for the evaluation of Campylobacter colonization in the gastric antrum. Schweiz. Rundsch. Med. Prax. 1990; 79: 389-90.
19. de Laat LE, de Boer WA. The CLO test as a reference method for Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 2001; 13: 1269-70.
20. Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J. Gastroenterol. 2007; 13: 6009-15.
21. Chen MJ, Lee YC, Chiu HM, Wu MS, Wang HP, Lin JT. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience. Dis. Esophagus 2010; 23: 201-7.
22. Belhocine K, Galmiche JP. Epidemiology of the complications of gastroesophageal reflux disease. Dig. Dis. 2009; 27: 7-13.
23. Sakaguchi M, Oka H, Hashimoto T etal. Obesity as a risk factor for GERD in Japan. J. Gastroenterol. 2008; 43: 57-62.
24. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am. J. Gastroenterol. 2005; 100: 1243-50.
25. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000; 118: 688-95.
26. de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am. J. Gastroenterol. 2008; 103: 1349-54.
27. Wang FW, Tu MS, Chuang HY, Yu HC, Cheng LC, Hsu PI. Erosive esophagitis in asymptomatic subjects: risk factors. Dig. Dis. Sci. 2010; 55: 1320-4.
28. Fass R, Sampliner RE, Mackel C, McGee D, Rappaport W. Age- and gender-related differences in 24-h esophageal pH monitoring of normal subjects. Dig. Dis. Sci. 1993; 38: 1926-8.
29. Festi D, Scaioli E, Baldi F etal. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J. Gastroenterol. 2009; 15: 1690-701.
30. Karoui S, Chtara O, Bibani N etal. Sleep disorders in patients with gastroesophageal reflux disease: an open clinical and pH metric prospective study. Tunis. Med. 2010; 88: 172-7.
31. Fujiwara Y, Kohata Y, Kaji M etal. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. Digestion 2010; 81: 135-41.
32. Yi CH, Hu CT, Chen CL. Sleep dysfunction in patients with GERD: erosive versus nonerosive reflux disease. Am. J. Med. Sci. 2007; 334: 168-70.